Obtained written alignment from the FDA on key elements of TSHA-102 pivotal Part B trial design and next steps on enabling ...

Gene therapy is at the cutting edge of medicine, with exciting new products being developed and used to treat a wide variety ...

Scientists at the McGovern Institute and the Broad Institute of MIT and Harvard have reengineered a compact RNA-guided enzyme ...

NewBiologix, a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through a unique DNA-based platform built on stable cell line ...

Hovione and Firstgene enter strategic collaboration to advance virus-like particle platform for liver cancer: Lisbon, Portugal Thursday, May 15, 2025, 13:00 Hrs [IST] Hovione, an ...

Biopharmas have been scaling back on AAV research for sometime now. Find out why and what's on the horizon for drug delivery ...

Xmoor Pharma has entered into a strategic partnership with KU Leuven to support a new cell and gene therapy hub.

Tenaya Therapeutics, Inc.’s TNYA share price has dipped by 5.10%, which has investors questioning if this is right time to ...

The UNC technology, developed by Pediatrics Professor Chengwen Li, M.D., Ph.D., uses adeno-associated viruses (AAVs) to ferry ...

Mass photometry enables rapid, purification-free quantification of rAAV vectors, offering a faster solution for gene therapy ...

BACKGROUND: Exercise improves functional outcomes in patients with diabetic cardiomyopathy (DiaCM). The molecular mechanism underlying cardiac benefits of exercise in DiaCM remains incompletely ...